

Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops a pipeline of multiple all...
Q2 2026
Aug 12, 2026
Q1 2026
May 13, 2026
FY 2025
Mar 12, 2026
Q4 2025
Mar 12, 2026
Q3 2025
Nov 6, 2025